Edward Benz

Alternative Text

Edward Benz, MD is President/CEO Emeritus of Dana-Farber Cancer Institute, CEO Emeritus of Dana-Farber/Partners Cancer Care, Director Emeritus of Dana-Farber/Harvard Cancer Center, Richard and Susan Smith Distinguished Professor of Medicine, Professor of Pediatrics, Professor of Genetics and Faculty Dean Emeritus for Oncology at Harvard Medical School.

A molecular hematologist specializing in inherited anemias and hemoglobinopathies, he has received more than 40 years of continuous NIH funding, and continues to lead an active laboratory studying the molecular genetics of the red cell cytoskeleton. He is board certified in Internal Medicine and Hematology, a Fellow of the American College of Physicians, and an elected Fellow of the American Association for the Advancement of Science. He previously served on the Hematology Board of the American Board of Internal Medicine, and as Associate Editor of Blood and The New England Journal of Medicine. In 2018, he was appointed the Executive Director of the Cure Sickle Cell Initiative, an NIH effort to accelerate definitive genetic therapies for sickle cell syndromes. Past President of the American Society for Clinical Investigation, the American Society of Hematology, the Association of American Cancer Institutes, Friends of the National Institute of Nursing Research, and the American Clinical and Climatological Association, he has been elected to Phi Beta Kappa, Sigma Xi, Alpha Omega Alpha, the National Academy of Medicine, the American Society for Clinical Investigation, Association of American Physicians, and the American Academy of Arts & Sciences. He previously served as the Sir William Osler Professor, Professor of Molecular Genetics and Biology, Chair of Medicine, and Physician in Chief at Johns Hopkins, Chair of Medicine and Physician in Chief at the University of Pittsburgh, and Chief of Hematology and Vice Chair of Internal Medicine and Genetics at Yale. He received his B.A. (cum laude) in Biochemistry from Princeton University, his M.D. (magna cum laude) from Harvard, where he won the Soma Weiss and Leon Resnick Awards for Undergraduate Research, His residency training in internal medicine at the Peter Bent Brigham Hospital, and his fellowships in Hematology at Yale.